SRA Wins $100 M Contract with DoD

• Program to Support Congressionally Directed Medical Research Programs

(Fairfax, Va., August 10, 2010) -- SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced that the Department of Defense (DoD) awarded the company a re-compete contract to support the receipt and scientific review of research grant applications for DoD's Congressionally Directed Medical Research Programs (CDMRP). The contract has a potential total dollar value of $100 million over five years, if all options are exercised.

SRA has provided a vast range of services supporting scientific and technical merit review of the thousands of research grant applications received by the U.S. Army Medical Research and Materiel Command's (USAMRMC) CDMRP. Research initiatives supported by SRA have included breast, prostate and ovarian cancers; chronic myelogenous leukemia; osteoporosis; neurofibromatosis; tuberous sclerosis complex; autism spectrum disorder, amyotrophic lateral sclerosis, post traumatic stress disorder, traumatic brain injury, prion diseases; and initiatives related to the health and readiness of military personnel.

"CDMRP plays an important role in supporting disease-specific research, and in addressing the issues faced by our military members and their families. SRA fully shares this mission and we are proud that CDMRP will allow us to continue this partnership," said SRA Health Programs Vice President Paul Nedzbala. "By leveraging our scientific expertise, information technology and administrative support, SRA has been able to provide an unsurpassed level of service to CDMRP. Our team is focused on CDMRP's mission as we make meaningful contributions to advances in important areas of biomedical research."

A centerpiece of SRA's support for CDMRP (and other scientific peer review clients) is its proprietary Program and Peer Review Management Information System (P2RMIS(R)) application, which supports the scientific review process, including online application evaluation and scoring, meeting and travel support, document management and information reporting. P2RMIS also houses a database of thousands of scientific professionals who have served on peer review panels and/or who are available to serve.

CDMRP holds a highly respected position in the research community for its emphasis on investment strategies that fill unique gaps and seek innovative ideas with the capacity to effect transformational change in the treatment of targeted diseases and conditions. CDMRP is rare among federal grant makers because of its emphasis on meaningful consumer engagement, disease-specific approach, pursuit of innovative research and two-tiered review process that results in funding decisions based on technical merit and programmatic relevance.

Source : SRA International